← Back to all trials
Completed
NCT07722351
Homocysteic Acid Biostimulator for Photoaged Facial Skin
Conditions: Skin Aging, Hyperpigmentation
Sex: Female
Ages: 39 Years – 69 Years
Healthy volunteers: No
Phase: NA
Enrollment: 25
Sponsor: Medical University of Silesia
Location: Department of Practical Cosmetology and Skin Diagnostics, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice Sosnowiec
Summary
This study evaluated whether a chemical skin biostimulator containing ammonium trichloroacetate, homocysteic acid, phytic acid and citric acid can improve signs of photoaged skin in women with mature skin. Twenty-five women received four treatment sessions two weeks apart, followed by a home-care skincare regimen. Skin firmness, wrinkles, skin texture, hydration, sebum production and, in participants with hyperpigmentation, skin tone uniformity were measured before treatment and at 2 and 12 weeks after the treatment series to determine whether the biostimulator produces lasting improvement in photoaged skin without the downtime associated with traditional chemical peels.
Eligibility Criteria
Inclusion Criteria:
* Female, Fitzpatrick skin phototype II
* Age 39-69 years
* Clinical signs of facial photoaging
* Some participants had hyperpigmentation (melasma or post-inflammatory hyperpigmentation)
Exclusion Criteria:
* Pregnancy or breastfeeding
* Ongoing hormone therapy
* Systemic corticosteroid use within 3 months prior to inclusion
* Topical retinoid use within 1 month, or oral retinoid use within 6 months, prior to treatment
* Chemical peel procedures within 1 month prior to treatment
* Use of arbutin and/or hydroquinone within 3 months prior to treatment
* Laser-based treatments within 3 months prior to treatment
* Active inflammatory dermatoses
* Autoimmune diseases
* Renal impairment
Source: ClinicalTrials.gov (NCT07722351). StuddyBuddy aggregates publicly available trial information.